SCHEDULE 13G/A

Allogene Therapeutics Inc

Common Stock · CUSIP: 019770106

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Arie Belldegrun, M.D.

  Shares: 12,393,567.00 · Class: 5.8%

• Bellco Legacy LLC

  Shares: 539,867.00 · Class: 0.3%

• Bellco Legacy IV LLC

  Shares: 4,710,120.00 · Class: 2.2%

• Vida Ventures LLC

  Shares: 1,798,163.00 · Class: 0.8%

• Vida Ventures III, L.P.

  Shares: 1,720,172.00 · Class: 0.8%

• Vida Ventures III-A, L.P.

  Shares: 3,965.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.